Molecular Markers in the Treatment of Endometrial Cancer 2

Phase 4

Recruiting

• Conditions: cancer of the womb; Endometrial carcinoma; 10038594

• Registration Number: NL-OMON49578
• Lead Sponsor: Haukeland University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 500

Inclusion Criteria

All patients with a diagnosis of endometrial cancer, histologically proven by
means of preoperative endometrial sampling.

Exclusion Criteria

Patients who will or cannot give informed consent (including language barriers)
Patients <18 years of age
Patients who will not receive surgical treatment for their endometrial cancer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Presence of lymph node metastasis</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Prognostic impact (overall survival, disease specific survival, recurrence-free<br /><br>survival)<br /><br>Quality of life</p><br>